Moisand Fitzgerald Tamayo’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
30
﹤0.01% 319
2026
Q1
$14.7K Hold
30
﹤0.01% 300
2025
Q4
$17.4K Hold
30
﹤0.01% 288
2025
Q3
$14.6K Hold
30
﹤0.01% 310
2025
Q2
$12.2K Hold
30
﹤0.01% 329
2025
Q1
$14.9K Hold
30
﹤0.01% 299
2024
Q4
$15.6K Hold
30
﹤0.01% 287
2024
Q3
$18.6K Hold
30
﹤0.01% 287
2024
Q2
$16.6K Hold
30
﹤0.01% 265
2024
Q1
$17.4K Hold
30
﹤0.01% 264
2023
Q4
$15.9K Sell
30
-8
-21% -$3.87K ﹤0.01% 282
2023
Q3
$19.2K Hold
38
﹤0.01% 265
2023
Q2
$19.8K Hold
38
﹤0.01% 252
2023
Q1
$21.9K Hold
38
﹤0.01% 249
2022
Q4
$20.9K Buy
38
+30
+375% +$15.9K ﹤0.01% 247
2022
Q3
$4K Buy
+8
New +$4.48K ﹤0.01% 415
2021
Q1
Sell
-10
Closed -$5K 401
2020
Q4
$5K Buy
+10
New +$4.69K ﹤0.01% 265
2018
Q1
Sell
-16
Closed -$3K 339
2017
Q4
$3K Hold
16
﹤0.01% 241
2017
Q3
$3K Buy
+16
New +$2.9K ﹤0.01% 263

Other funds holding TMO

Moisand Fitzgerald Tamayo's TMO Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 30 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Moisand Fitzgerald Tamayo first reported a position in TMO in Q3 2017 and has held it in 19 quarters since. The position peaked at $21.9K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Moisand Fitzgerald Tamayo held 30 shares of Thermo Fisher Scientific worth $15K as of Q2 2026.
  • Moisand Fitzgerald Tamayo left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #319 holding.
  • Moisand Fitzgerald Tamayo first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 19 quarters since.
  • Moisand Fitzgerald Tamayo's Thermo Fisher Scientific position peaked at $21.9K in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.